Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Mirza Nadeem Q. — Aprea Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Mirza Nadeem Q.

Mirza Nadeem Q.

Chief Medical Officer at Aprea Therapeutics, Inc. · on record since May 2, 2024

Insider trading activity of Mirza Nadeem Q.

Transactions on record: 2; since May 2, 2024

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing May 2, 2024

Figures computed from official regulatory filings — methodology.

Companies where Mirza Nadeem Q. has traded

Aprea Therapeutics, Inc.2 tx · May 2, 2024

Track record of Mirza Nadeem Q.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Mirza Nadeem Q.

Co-insiders of Mirza Nadeem Q.

5AM Co-Investors IV, L.P.Aprea Therapeutics, Inc.
5AM Opportunities I (GP), LLCAprea Therapeutics, Inc.
5AM Opportunities I, L.P.Aprea Therapeutics, Inc.
5AM Partners IV, LLCAprea Therapeutics, Inc.
5AM Ventures IV, L.P.Aprea Therapeutics, Inc.
Abrahmsen Lars B.Aprea Therapeutics, Inc.
Attar Eyal C.Aprea Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BIZZARI JEAN-PIERREAprea Therapeutics, Inc.

Christenson JohanAprea Therapeutics, Inc.

Coiante Scott MAprea Therapeutics, Inc.

DIEKMAN JOHN DAprea Therapeutics, Inc.

Duey MarcAprea Therapeutics, Inc.

Gilad OrenAprea Therapeutics, Inc.

Green JeremyAprea Therapeutics, Inc.

Grissinger MichaelAprea Therapeutics, Inc.

Gruia GabrielaAprea Therapeutics, Inc.

Hamill John P.Aprea Therapeutics, Inc.

HealthCap VII GP S.A.Aprea Therapeutics, Inc.

HealthCap VII, L.P.Aprea Therapeutics, Inc.

HENNEMAN JOHN B IIIAprea Therapeutics, Inc.

Hepple JonathanAprea Therapeutics, Inc.

Karolinska Development ABAprea Therapeutics, Inc.

KCIF Co-Investment Fund KBAprea Therapeutics, Inc.

KDev Investments ABAprea Therapeutics, Inc.

Kelly Michael AaronAprea Therapeutics, Inc.

Korbel Gregory AlanAprea Therapeutics, Inc.

Magni GuidoAprea Therapeutics, Inc.

Namouni FouadAprea Therapeutics, Inc.

Pamukcu RifatAprea Therapeutics, Inc.

PARMAR KUSHAprea Therapeutics, Inc.

Peters RichardAprea Therapeutics, Inc.

Redmile Group, LLCAprea Therapeutics, Inc.

ROCKLAGE SCOTT MAprea Therapeutics, Inc.

SCHADE CHRISTIAN SAprea Therapeutics, Inc.

Schwab Andrew J.Aprea Therapeutics, Inc.

Seizinger Bernd R.Aprea Therapeutics, Inc.

Versant Affiliates Fund V, L.P.Aprea Therapeutics, Inc.

Versant Ophthalmic Affiliates I, L.P.Aprea Therapeutics, Inc.

Versant Vantage I GP-GP, LLCAprea Therapeutics, Inc.

Versant Vantage I GP, L.P.Aprea Therapeutics, Inc.

Versant Vantage I, L.P.Aprea Therapeutics, Inc.

Versant Venture Capital V (Canada), LPAprea Therapeutics, Inc.

Versant Venture Capital V, L.P.Aprea Therapeutics, Inc.

Versant Ventures V (Canada), L.P.Aprea Therapeutics, Inc.

Versant Ventures V GP-GP (Canada), Inc.Aprea Therapeutics, Inc.

Versant Ventures V, LLCAprea Therapeutics, Inc.

Versant V Luxco S.a r.l.Aprea Therapeutics, Inc.

Wessels Gregory S.Aprea Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Aprea Therapeutics, Inc.	May 2, 2024	AwardD	26,920	0.00 USD	$0	SEC
Aprea Therapeutics, Inc.	May 2, 2024	Award	6,730	0.00 USD	$0	SEC